Bionano Genomics, Inc. (Nasdaq: BNGO) today announced that it will host a conference call and live webcast on Wednesday, May 13, 2026, at 4:30 p.m. Eastern Time to report financial results for the ...

Bionano Genomics (NASDAQ:BNGO) is a life sciences instrumentation company focused on the genome analysis space. Its products include Saphyr, Bionano Chips, Bionano Prep Kits, and Bionano Data ...

Investors interested in Medical stocks should always be looking to find the best-performing companies in the group. Is Bionano Genomics, Inc. (BNGO) one of those stocks right now? By taking a look at ...

Bionano Genomics, a company that develops technology for cancer research and diagnosis, is burning through cash at an unsustainable rate, despite its high revenue growth. The company's total ...

High-flying growth stocks like Bionano Genomics (NASDAQ: BNGO) tend to be controversial among different crowds of investors. Where some might see a stock's potential to multiply in value over time by ...

Bionano Genomics, Inc. today announced the Stratys ™ system for high throughput optical genome mapping (OGM) and VIA ™ software for visualization, interpretation and reporting of genome analysis for ...

Bionano original equipment manufacturing (OEM) partner A-smart MedTech (A-smart) obtained reagent class I registration and approval for DNA isolation and labeling kits for optical genome mapping (OGM) ...

Bionano says it expects another quarter of revenue growth. The company makes genomic testing equipment. Bionano has been consistently unprofitable. Bionano said it expected revenue of $7.3 million to ...

Participants may access a live webcast of the call on the Investors page of the Bionano website. A replay of the conference call and webcast will be archived on ...